SENATE 366116th CongressRead twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)
FLAT Prices Act
- Last Action
- 2/6/2019
Actions
- 2019-02-06Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)
- 2019-02-06Introduced in Senate
CRS Summary
As of 2019-02-06 (00)
Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act
This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.